Provexis (PXS) Competitors GBX 0.80 -0.07 (-7.51%) As of 03:59 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock PXS vs. NSH, ALK, CLCO, ICON, PAA, GEL, MMP, AAL, CCL, and SAVEShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), Carnival Co. & (CCL), and Savannah Energy (SAVE). These companies are all part of the "transportation" industry. Provexis vs. Its Competitors Norish Alkemy Capital Investments CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Anglo American Carnival Co. & Savannah Energy Provexis (LON:PXS) and Norish (LON:NSH) are both small-cap transportation companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership. Is PXS or NSH more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets Provexis-73.10% -68.68% -56.14% Norish N/A N/A N/A Does the media refer more to PXS or NSH? In the previous week, Provexis had 1 more articles in the media than Norish. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Norish. Provexis' average media sentiment score of 1.02 beat Norish's score of 0.00 indicating that Provexis is being referred to more favorably in the media. Company Overall Sentiment Provexis Positive Norish Neutral Which has higher earnings and valuation, PXS or NSH? Norish has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Norish, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProvexis£846.98K22.16-£619.15K-£0.03-30.33Norish£36.39M0.00N/A£6.10N/A Do insiders & institutionals have more ownership in PXS or NSH? 7.9% of Provexis shares are held by institutional investors. 21.6% of Provexis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryNorish beats Provexis on 6 of the 10 factors compared between the two stocks. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£18.77M£2.16B£5.54B£2.95BDividend Yield5.06%2.92%5.39%5.02%P/E Ratio-30.334.1526.19145.28Price / Sales22.16586.68414.04254,087.76Price / CashN/A10.3536.1327.97Price / Book93.2612.298.025.28Net Income-£619.15K£21.15B£3.15B£5.90B7 Day Performance23.08%2.53%1.48%0.30%1 Month Performance46.79%5.22%3.67%4.85%1 Year Performance43.37%2.88%34.68%80.64% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.80-7.5%N/A+45.4%£18.77M£846.98K-30.334Positive NewsGap UpNSHNorishN/AN/AN/AN/A£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 171.80+0.2%N/A+152.4%£15.14MN/A-11.7825,500CLCOCloudCoCo GroupN/AGBX 0.22-14.6%N/A-19.7%£1.60M£27.84M-0.76125Earnings ReportGap UpICONIconic LabsN/AGBX 2.25-18.2%N/A-45.6%£251K£600.86K-6.433News CoverageGap UpPAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660AALAnglo American0.9815 of 5 starsGBX 2,151+0.3%GBX 2,330+8.3%-5.5%£32.71B£36.94B-19.81129,700Positive NewsCCLCarnival Co. &N/AGBX 1,782+3.9%N/A+52.7%£32.20B£32.78B16.1540,000SAVESavannah EnergyN/AGBX 7.50flatN/AN/A£9.84B£18.46B-4.8711,100Gap Down Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Anglo American Alternatives Carnival Co. & Alternatives Savannah Energy Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PXS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
